TY - JOUR
T1 - Late-onset ornithine transcarbamylase deficiency
T2 - Treatment and outcome of hyperammonemic crisis
AU - Bergmann, Kelly R.
AU - McCabe, James
AU - Smith, T. Ryan
AU - Guillaume, Daniel J.
AU - Sarafoglou, Kyriakie
AU - Gupta, Sameer
PY - 2014/4
Y1 - 2014/4
N2 - Hyperammonemic crises in ornithine transcarbamylase deficiency (OTC) can be associated with devastating cerebral edema resulting in severe long-term neurologic impairment and death. We present an 8-year-old boy who had late-onset OTC deficiency in which early and aggressive management of hyperammonemia and associated cerebral edema, including therapeutic hypothermia and barbiturateinduced coma, resulted in favorable neurologic outcome. Our patient presented with vomiting and altered mental status, and was found to have a significantly elevated serum ammonia level of 1561 mmol/L. Hyperammonemia was managed with hemodialysis, 10% sodium phenylacetate, 10% sodium benzoate, L-arginine, intravenous 10% dextrose, intralipids, and protein restriction. He developed significant cerebral edema with intracranial pressures >20 mm Hg, requiring treatment with 3% saline and mannitol. Despite this treatment our patient continued to have elevated intracranial pressures, which were treated aǵǵressively with non-conventional modalities including therapeutic hypothermia, barbiturate-induced coma, and external ventricular drainage. This therapy resulted in stabilization of hyperammonemia and resolution of cerebral edema. Molecular testing later revealed a hemizygous mutation within the OTC ǵene. Neuropsycholoǵical testing 1 year after discharǵe showed normal intelligence with no visualmotor deficits, minor deficits in working memory and processing speed, and slightly below average processing speed and executive functioning.
AB - Hyperammonemic crises in ornithine transcarbamylase deficiency (OTC) can be associated with devastating cerebral edema resulting in severe long-term neurologic impairment and death. We present an 8-year-old boy who had late-onset OTC deficiency in which early and aggressive management of hyperammonemia and associated cerebral edema, including therapeutic hypothermia and barbiturateinduced coma, resulted in favorable neurologic outcome. Our patient presented with vomiting and altered mental status, and was found to have a significantly elevated serum ammonia level of 1561 mmol/L. Hyperammonemia was managed with hemodialysis, 10% sodium phenylacetate, 10% sodium benzoate, L-arginine, intravenous 10% dextrose, intralipids, and protein restriction. He developed significant cerebral edema with intracranial pressures >20 mm Hg, requiring treatment with 3% saline and mannitol. Despite this treatment our patient continued to have elevated intracranial pressures, which were treated aǵǵressively with non-conventional modalities including therapeutic hypothermia, barbiturate-induced coma, and external ventricular drainage. This therapy resulted in stabilization of hyperammonemia and resolution of cerebral edema. Molecular testing later revealed a hemizygous mutation within the OTC ǵene. Neuropsycholoǵical testing 1 year after discharǵe showed normal intelligence with no visualmotor deficits, minor deficits in working memory and processing speed, and slightly below average processing speed and executive functioning.
KW - Barbiturates
KW - Cerebral edema
KW - Hyperammonemia
KW - Induced hypothermia
KW - Intracranial hypertension
KW - Ornithine transcarbamylase deficiency
KW - Inborn errors of metabolism
UR - http://www.scopus.com/inward/record.url?scp=84898714936&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898714936&partnerID=8YFLogxK
U2 - 10.1542/peds.2013-1324
DO - 10.1542/peds.2013-1324
M3 - Article
C2 - 24616362
AN - SCOPUS:84898714936
SN - 0031-4005
VL - 133
SP - e1072-e1076
JO - Pediatrics
JF - Pediatrics
IS - 4
ER -